Caladrus Biosciences (CLBS:NASDAQ) Investor Relations Material

Overview

Caladrius Biosciences Inc., a prominent American biopharmaceutical company, has been making waves in the cell therapy industry due to its subsidiary PCT's expertise in development and manufacturing of cell therapies. PCT has emerged as a key partner for companies in the cell therapy domain, supporting several clinical trials and working on the production of tailored cell therapy treatments. With a strong track record of success and adoption across the sector, the company stands as a solid bet for investors looking to bank on the future of cell therapy.

Frequently Asked Questions

What is Caladrus Biosciences's ticker?

Caladrus Biosciences's ticker is CLBS

What exchange is Caladrus Biosciences traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Caladrus Biosciences's headquarters?

They are based in Basking Ridge, New Jersey

How many employees does Caladrus Biosciences have?

There are 51-200 employees working at Caladrus Biosciences

What is Caladrus Biosciences's website?

It is http://www.caladrius.com/

What type of sector is Caladrus Biosciences?

Caladrus Biosciences is in the Healthcare sector

What type of industry is Caladrus Biosciences?

Caladrus Biosciences is in the Biotechnology industry

Who are Caladrus Biosciences's peers and competitors?

The following five companies are Caladrus Biosciences's industry peers:

- Sangamo Therapeutics

- Nuformix plc

- Exicure, Inc.

- BeyondSpring, Inc.

- Checkpoint Therapeutics, Inc.